Patents

  squares  Home

  squares  Company

  squares  Products

  squares  Technology

  squares  News &
      Events


  squares  Glossary
Technology>>   SOMAmers   Publications   Patents

Aptamers represent a novel approach for capturing and analyzing proteins, and SomaLogic is the undisputed leader in this arena.

 


Aptamers were discovered at the University of Colorado by Dr. Larry Gold, SomaLogic's founder, chairman and CSO. The company's team includes many of the pioneers in the aptamer field, and SomaLogic has developed an extraordinarily strong portfolio of intellectual property around aptamers and their in vitro diagnostic and research applications.

SomaLogic has licensed from Gilead Sciences, Inc. the worldwide exclusive rights to the entire aptamer patent estate for in vitro diagnostics (Gilead obtained the technology in its 1999 acquisition of Boulder, Colorado-based NeXstar, Inc.). In addition, SomaLogic owns critical U.S. patents and applications, and the company continues its research to broaden the applications of aptamers and establish them as the preferred technology for proteomics. Patent applications have been filed throughout the world, providing the basis for the development of a truly global business.

In addition to the select patents below, you can review the full list of more than 160 issued U.S. patents. You can read the actual patents at the U.S. Patent & Trademark Office.

 

return to top

Key Issued SELEX Process Patents
Owned or Licensed by SomaLogic

Title United States
Patent Number
Issue Date
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands 6,482,594 11/19/02
Nucleic acid ligand diagnostic biochip 6,458,543 10/01/02
Photoselection of nucleic acid ligands 6,458,539 10/01/02
Modified SELEX processes without purified protein 6,376,190 04/23/02
Methods of producing nucleic acid ligands 6,344,318 02/05/02
Nucleic Acid Ligand Diagnostic Biochip 6,242,246 06/05/01
High Affinity Nucleic Acid Ligands Containing Modified Nucleotides 6,184,364 02/06/01
Systematic Evolution of Ligands by Exponential Enrichment: Photoselection of Nucleic Acid Ligands and Solution SELEX 6,001,577 12/14/99
High Affinity Nucleic Acid Ligands Containing Modified Nucleotides 5,958,691 09/28/99
Method for Detecting a Target Compound in a Substance using a Nucleic Acid Ligand 5,874,218 02/23/99
Use of Nucleic Acid Ligands in Flow Cytometry 5,853,984 12/29/98
Method and Apparatus for Determining Consensus Secondary Structures for Nucleic Acid Sequences 5,843,732 12/01/98
Method for Detecting a Target Molecule in a Sample Using a Nucleic Acid Ligand 5,843,653 12/01/98
Method of Producing Nucleic Acid Ligands 5,817,785 10/6/98
Enzyme Linked Oligonucleotide Assays (ELONAS) 5,789,163 08/04/98
Systematic Evolution of Ligands by Exponential Enrichment: Photoselection of Nucleic Acid Ligands and Solution Selex 5,763,177 06/9/98
Nucleic Acid Ligands (SELEX) 5,696,249 12/09/97
High Affinity Nucleic Acid Ligands Containing Modified Nucleotides 5,660,985 08/26/97
Method of Producing Nucleic Acid Ligands 5,595,877 01/21/97
Solution SELEX 5,567,588 10/22/96
Nucleic Acid Ligands 5,270,163 12/14/93

 

return to top

 



legal   privacy   contact   sitemap